Kevin Marsh/BMC Med
Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya.Njuguna, P.
Maitland, K.
Nyaguara, A.
Mwanga, D.
Mogeni, P.
Mturi, N.
Mohammed, S.
Mwambingu, G.
Ngetsa, C.
Awuondo, K.
Lowe, B.
Adetifa, I.
Scott, J. A. G.
Williams, T. N.
Atkinson, S.
Osier, F.
Snow, R. W.
Marsh, K.
Tsofa, B.
Peshu, N.
Hamaluba, M.
Berkley, J. A.
Newton, C. R. J.
Fondo, J.
Omar, A.
Bejon, P.
BMC Med, (2019). 17:124
Repeated clinical malaria episodes are associated with modification of the immune system in children.Bediako, Y.
Adams, R.
Reid, A. J.
Valletta, J. J.
Ndungu, F. M.
Sodenkamp, J.
Mwacharo, J.
Ngoi, J. M.
Kimani, D.
Kai, O.
Wambua, J.
Nyangweso, G.
de Villiers, E. P.
Sanders, M.
Lotkowska, M. E.
Lin, J. W.
Manni, S.
Addy, J. W. G.
Recker, M.
Newbold, C.
Berriman, M.
Bejon, P.
Marsh, K.
Langhorne, J.
BMC Med, (2019). 17:60
The effect of declining exposure on T cell-mediated immunity to Plasmodium falciparum - an epidemiological "natural experiment".Bediako, Y.
Ngoi, J. M.
Nyangweso, G.
Wambua, J.
Opiyo, M.
Nduati, E. W.
Bejon, P.
Marsh, K.
Ndungu, F. M.
BMC Med, (2016). 14:143
Identifying children with excess malaria episodes after adjusting for variation in exposure: identification from a longitudinal study using statistical count models.Ndungu, F. M.
Marsh, K.
Fegan, G.
Wambua, J.
Nyangweso, G.
Ogada, E.
Mwangi, T.
Nyundo, C.
Macharia, A.
Uyoga, S.
Williams, T. N.
Bejon, P.
BMC Med, (2015). 13:183
Malaria eradication and elimination: views on how to translate a vision into reality.Tanner, M.
Greenwood, B.
Whitty, C. J.
Ansah, E. K.
Price, R. N.
Dondorp, A. M.
von Seidlein, L.
Baird, J. K.
Beeson, J. G.
Fowkes, F. J.
Hemingway, J.
Marsh, K.
Osier, F.
BMC Med, (2015). 13:167
Multiple clinical episodes of Plasmodium falciparum malaria in a low transmission intensity setting: exposure versus immunity.Rono, J.
Farnert, A.
Murungi, L.
Ojal, J.
Kamuyu, G.
Guleid, F.
Nyangweso, G.
Wambua, J.
Kitsao, B.
Olotu, A.
Marsh, K.
Osier, F. H.
BMC Med, (2015). 13:114
Limited antigenic diversity of Plasmodium falciparum apical membrane antigen 1 supports the development of effective multi-allele vaccines.Terheggen, U.
Drew, D. R.
Hodder, A. N.
Cross, N. J.
Mugyenyi, C. K.
Barry, A. E.
Anders, R. F.
Dutta, S.
Osier, F. H.
Elliott, S. R.
Senn, N.
Stanisic, D. I.
Marsh, K.
Siba, P. M.
Mueller, I.
Richards, J. S.
Beeson, J. G.
BMC Med, (2014). 12:183
Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.Osier, F. H.
Feng, G.
Boyle, M. J.
Langer, C.
Zhou, J.
Richards, J. S.
McCallum, F. J.
Reiling, L.
Jaworowski, A.
Anders, R. F.
Marsh, K.
Beeson, J. G.
BMC Med, (2014). 12:108
Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.Warimwe, G. M.
Fletcher, H. A.
Olotu, A.
Agnandji, S. T.
Hill, A. V.
Marsh, K.
Bejon, P.
BMC Med, (2013). 11:184
